Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Dynamics of Polyglutamine-Expanded ATXN3 in Biofluids of Spinocerebellar Ataxia Type 3.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Cardiovascular Exercise Drives Neuroprotection in a Mouse Model of Spinocerebellar Ataxia 1 Via Rescue of Aberrant Splicing.

Annals of neurology·2026
Same author

Cognitive Fluctuations, Neuropsychiatric Burden, and Quality of Life in Moderate-Advanced Dementia With Lewy Bodies: The Role of Dysautonomia.

Neurology·2026
Same author

Early and Progressive Spinal Cord Atrophy in Spinocerebellar Ataxia Type 1.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Longitudinal and combined assessment of 24(S)-hydroxycholesterol and Neurofilament light chain in the early stages of Huntington's disease.

Neurobiology of disease·2026
Same author

Plasma neurofilament light is associated with hippocampal volume and memory performance but not functional connectivity in older adults with and without mild cognitive decline.

Aging brain·2026

Related Experiment Video

Updated: Jan 26, 2026

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
07:33

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia

Published on: May 21, 2010

37.2K

Spinocerebellar ataxia.

Thomas Klockgether1,2, Caterina Mariotti3, Henry L Paulson4

  • 1Department of Neurology, University of Bonn, Bonn, Germany. klockgether@uni-bonn.de.

Nature Reviews. Disease Primers
|April 13, 2019
PubMed
Summary

Spinocerebellar ataxias (SCAs) are inherited neurological disorders affecting balance and coordination. Current research reveals disease mechanisms and potential targets, but SCA heterogeneity necessitates individualized treatments.

More Related Videos

Purification of Prominin-1+ Stem Cells from Postnatal Mouse Cerebellum
07:04

Purification of Prominin-1+ Stem Cells from Postnatal Mouse Cerebellum

Published on: April 12, 2020

6.3K
A Standardized Pipeline for Examining Human Cerebellar Grey Matter Morphometry using Structural Magnetic Resonance Imaging
11:50

A Standardized Pipeline for Examining Human Cerebellar Grey Matter Morphometry using Structural Magnetic Resonance Imaging

Published on: February 4, 2022

4.6K

Related Experiment Videos

Last Updated: Jan 26, 2026

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
07:33

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia

Published on: May 21, 2010

37.2K
Purification of Prominin-1+ Stem Cells from Postnatal Mouse Cerebellum
07:04

Purification of Prominin-1+ Stem Cells from Postnatal Mouse Cerebellum

Published on: April 12, 2020

6.3K
A Standardized Pipeline for Examining Human Cerebellar Grey Matter Morphometry using Structural Magnetic Resonance Imaging
11:50

A Standardized Pipeline for Examining Human Cerebellar Grey Matter Morphometry using Structural Magnetic Resonance Imaging

Published on: February 4, 2022

4.6K

Area of Science:

  • Neuroscience
  • Genetics
  • Neurology

Background:

  • Spinocerebellar ataxias (SCAs) are a group of inherited, progressive neurological disorders.
  • Characterized by loss of balance, coordination, and slurred speech, typically with adult onset.
  • SCAs exhibit genetic heterogeneity, including repeat expansion and non-repeat mutation types.

Purpose of the Study:

  • To review the genetic heterogeneity and pathobiology of SCAs.
  • To highlight the current understanding of disease mechanisms.
  • To discuss challenges and opportunities in developing targeted therapies.

Main Methods:

  • Review of existing literature on SCA genetics and pathobiology.
  • Analysis of common and rare SCA subtypes.
  • Examination of molecular mechanisms underlying neurodegeneration in SCAs.

Main Results:

  • SCAs involve diverse genetic causes and affect cerebellar Purkinje neurons and other nervous system parts.
  • Pathogenic mechanisms include proteotoxicity, RNA toxicity, and ion channel dysfunction.
  • No current treatments halt SCA progression; management focuses on symptom relief.

Conclusions:

  • Understanding SCA pathobiology has identified potential therapeutic targets.
  • The genetic and clinical heterogeneity of SCAs presents a significant challenge for developing effective, universal treatments.
  • Tailored therapeutic strategies are likely required for different SCA subtypes.